HIV-1 integrase inhibitors (Universite Paris-Sud/Institut Gustave Roussy/CNRS)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHIV-1 integrase inhibitors (Universite Paris-Sud/Institut Gustave Roussy/CNRS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversite Paris Sud XI
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversite Paris Sud XICentre National De La Recherche Scientifique (Cnrs) +[3] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A